Skip to the content

FDA Medical Device Recalls (openFDA)

Remel Inc: Oxoid Nitrocefin (+ Reconstitution Fluid Batch) REF: SR0112C, Oxoid Ltd. For the rapid chromogenic detection of beta-lactamase activity in bacterial cells. in vitro diagnostic

Recall number
Z-1921-2016
Recalling firm
Remel Inc
Product
Oxoid Nitrocefin (+ Reconstitution Fluid Batch) REF: SR0112C, Oxoid Ltd. For the rapid chromogenic detection of beta-lactamase activity in bacterial cells. in vitro diagnostic
Status
Terminated
Initiated
2016-03-24
Posted
not on file
Terminated
2017-02-13
Reason
Individual bottles of product may produce weak beta-lactamase reactions. Use may result in delayed or false negative reporting.
Root cause
Under Investigation by firm
Action
Customers were notified by letter beginning on March 24, 2016.
Quantity
2 units were imported and distributed domestically
Distribution
US distribution in MO.
Lot, serial or model codes
Lot 1717357 Exp: 31Aug2017
510(k) numbers
not on file
PMA numbers
not on file
Product code
JTT
Firm FEI
1924669
Firm city
Lenexa
Firm state
KS
Firm country
not on file

Where this comes from

Register
FDA Medical Device Recalls (openFDA)
Publisher
U.S. Food and Drug Administration (openFDA)
File
device-recall-0001-of-0001.json.zip
sha256
b87518bfe2e8
Size
288210821 bytes
Published
2026-09-28
Read
2026-09-29T08:25:23.626Z
Source file
Source file retained · verify
Refresh due
2026-10-06

Unless otherwise noted, the content, data, documentation, code, and related materials on openFDA is public domain and made available with a Creative Commons CC0 1.0 Universal dedication.

Cite as

FDA Medical Device Recalls (openFDA) (U.S. Food and Drug Administration (openFDA)), device-recall-0001-of-0001.json.zip, sha256 b87518bfe2e8, published 2026-09-28

Search this register